코미팜

041960KOSDAQView the 제약 sectorTheme Bio & healthcare

8,290KRWMarket close of 10/27 (Tue)

Up +0.12%+10KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)8,680KRWUp +4.70%

Preliminary · replaced once official KRX data for the same date is published

Open
8,250
High
8,440
Low
8,100
Day range
Day range low 8,100 high 8,440, open 8,250, close 8,290, previous close 8,280
Volume
23×10K shares
1.9B KRW 0.56× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 5,890 to 11,550 won, 42% up from the low

42% of the way up from the lowest close in 1 year (252 sessions) · -28.2% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Recent filingsnot verifiedCould not read filing data, so not verified
  • Daily moveusual range+0.12%+0.12%, 0.0× the usual (20-session average ±2.95%)
    That day +0.12% · usual ±2.95% · large-move threshold ±5.9%
  • Trading valueusual range0.6×1.9B KRW, 0.6× the 20-session average
    0.56× the 20-session average · check threshold 3×

The other 2 are within the usual range

  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Foreign & institutional-300.00 million KRWusual range
See the full check report

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 19 days
  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.